Gynecologic Cancer
Conference Coverage
Intervention reduced racial disparities among patients in cancer trials
A navigation program improved outcomes of Black women with endometrial cancer enrolled in clinical trials.
Conference Coverage
Delaying surgery didn’t impact survival in early-stage cervical cancer
The results are “reassuring” in light of the pandemic, according to an investigator.
Conference Coverage
Rucaparib extends PFS in BRCA-mutated ovarian cancer, with an exception
The PARP inhibitor was superior to chemotherapy, except in patients with BRCA reversion mutations.
From the Journals
Is the WHO’s HPV vaccination target within reach?
The WHO’s goal is to have HPV vaccines delivered to 90% of all adolescent girls by 2030.
From the Journals
SNP chips deemed ‘extremely unreliable’ for identifying rare variants
Single-nucleotide polymorphism chips are more likely to be wrong than right when it comes to rare variants, researchers say.
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Conference Coverage
Vaginal pH may predict CIN 2 progression in HIV-positive women
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Clinical Insights
Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?
Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.
From the Journals
Ovarian cancer prevention: How patients decide on surgery
Twenty-four women reveal how they made a difficult decision.
News from the FDA/CDC
Bladder cancer indication withdrawn for durvalumab
AstraZeneca has withdrawn durvalumab’s indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit...